SEARCH

SEARCH BY CITATION

References

  • ABRAHAM, R.T. & WIEDERRECHT, G.J. (1996). Immunopharmacology of rapamycin. Annu. Rev. Immunol., 14, 483510.
  • APPLEMAN, L.J., BEREZOVSKAYA, A., GRASS, I. & BOUSSIOTIS, V.A. (2000). CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol., 164, 144151.
  • APPLEMAN, L.J., VAN PUIJENBROEK, A.A., SHU, K.M., NADLER, L.M. & BOUSSIOTIS, V.A. (2002). CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol., 168, 27292736.
  • BARBET, N.C., SCHNEIDER, U., HELLIWELL, S.B., STANSFIELD, I., TUITE, M.F. & HALL, M.N. (1996). TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell, 7, 2542.
  • BEADLING, C., GUSCHIN, D., WITTHUHN, B.A., ZIEMIECKI, A., IHLE, J.N., KERR, I.M. & CANTRELL, D.A. (1994). Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J., 13, 56055615.
  • BOONEN, G.J., VAN DIJK, A.M., VERDONCK, L.F., VAN LIER, R.A., RIJKSEN, G. & MEDEMA, R.H. (1999). CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol., 29, 789798.
  • BRENNAN, P., BABBAGE, J.W., BURGERING, B.M., GRONER, B., REIF, K. & CANTRELL, D.A. (1997). Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity, 7, 679689.
  • BRENNAN, P., BABBAGE, J.W., THOMAS, G. & CANTRELL, D. (1999). p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol. Cell. Biol., 19, 47294738.
  • BURGERING, B.M. & KOPS, G.J. (2002). Cell cycle and death control: long live Forkheads. Trends Biochem. Sci., 27, 352360.
  • CRESPO, J.L., POWERS, T., FOWLER, B. & HALL, M.N. (2002). The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine. Proc. Natl. Acad. Sci. U.S.A., 99, 67846789.
  • FRAUWIRTH, K.A., RILEY, J.L., HARRIS, M.H., PARRY, R.V., RATHMELL, J.C., PLAS, D.R., ELSTROM, R.L., JUNE, C.H. & THOMPSON, C.B. (2002). The CD28 signaling pathway regulates glucose metabolism. Immunity, 16, 769777.
  • HAERYFAR, S.M. & HOSKIN, D.W. (2001). Selective pharmacological inhibitors reveal differences between Thy-1- and T cell receptor-mediated signal transduction in mouse T lymphocytes. Int. Immunopharmacol., 1, 689698.
  • HASHEMOLHOSSEINI, S., NAGAMINE, Y., MORLEY, S.J., DESRIVIERES, S., MERCEP, L. & FERRARI, S. (1998). Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem., 273, 1442414429.
  • HORI, T., UCHIYAMA, T., TSUDO, M., UMADOME, H., OHNO, H., FUKUHARA, S., KITA, K. & UCHINO, H. (1987). Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood, 70, 10691072.
  • HSUEH, Y.P., LIANG, H.E., NG, S.Y. & LAI, M.Z. (1997). CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. J. Immunol., 158, 8593.
  • KAHAN, B.D. (2003). Individuality: the barrier to optimal immunosuppression. Nat. Rev. Immunol., 3, 831838.
  • KIM, D.H., SARBASSOV, D.D., ALI, S.M., KING, J.E., LATEK, R.R., ERDJUMENT-BROMAGE, H., TEMPST, P. & SABATINI, D.M. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell, 110, 163175.
  • KOPS, G.J., MEDEMA, R.H., GLASSFORD, J., ESSERS, M.A., DIJKERS, P.F., COFFER, P.J., LAM, E.W. & BURGERING, B.M. (2002). Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol., 22, 20252036.
  • KURTS, C., KOSAKA, H., CARBONE, F.R., MILLER, J.F. & HEATH, W.R. (1997). Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med., 186, 239245.
  • LALI, F.V., CRAWLEY, J., MCCULLOCH, D.A. & FOXWELL, B.M. (2004). A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation. J. Immunol., 172, 35273534.
  • LEONARD, W.J. (2001). Cytokines and immunodeficiency diseases. Nat. Rev. Immunol., 1, 200208.
  • LUO, Y., MARX, S.O., KIYOKAWA, H., KOFF, A., MASSAGUE, J. & MARKS, A.R. (1996). Rapamycin resistance tied to defective regulation of p27Kip1. Mol. Cell. Biol., 16, 67446751.
  • MEDEMA, R.H., KOPS, G.J., BOS, J.L. & BURGERING, B.M. (2000). AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404, 782787.
  • MEHL, A.M., FLOETTMANN, J.E., JONES, M., BRENNAN, P. & ROWE, M. (2001). Characterization of intercellular adhesion molecule-1 regulation by Epstein–Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription. J. Biol. Chem., 276, 984992.
  • NELSON, B.H. & WILLERFORD, D.M. (1998). Biology of the interleukin-2 receptor. Adv. Immunol., 70, 181.
  • NOURSE, J., FIRPO, E., FLANAGAN, W.M., COATS, S., POLYAK, K., LEE, M.H., MASSAGUE, J., CRABTREE, G.R. & ROBERTS, J.M. (1994). Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372, 570573.
  • OEHEN, S. & BRDUSCHA-RIEM, K. (1999). Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies? Eur. J. Immunol., 29, 608614.
  • OKKENHAUG, K., BILANCIO, A., FARJOT, G., PRIDDLE, H., SANCHO, S., PESKETT, E., PEARCE, W., MEEK, S.E., SALPEKAR, A., WATERFIELD, M.D., SMITH, A.J. & VANHAESEBROECK, B. (2002). Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science, 297, 10311034.
  • SADHU, C., DICK, K., TINO, W.T. & STAUNTON, D.E. (2003a). Selective role of PI3K delta in neutrophil inflammatory responses. Biochem. Biophys. Res. Commun., 308, 764769.
  • SADHU, C., MASINOVSKY, B., DICK, K., SOWELL, C.G. & STAUNTON, D.E. (2003b). Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J. Immunol., 170, 26472654.
  • SHERR, C.J. (1996). Cancer cell cycles. Science, 274, 16721677.
  • STAHL, M., DIJKERS, P.F., KOPS, G.J., LENS, S.M., COFFER, P.J., BURGERING, B.M. & MEDEMA, R.H. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol., 168, 50245031.
  • VLAHOS, C.J., MATTER, W.F., HUI, K.Y. & BROWN, R.F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269, 52415248.
  • WARD, S.G. & CANTRELL, D.A. (2001). Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol., 13, 332338.
  • YUSUF, I. & FRUMAN, D.A. (2003). Regulation of quiescence in lymphocytes. Trends Immunol., 24, 380386.